140 related articles for article (PubMed ID: 38158026)
1. Strategies for studying immune and non-immune human and canine mammary gland cancer tumour infiltrate.
Rodríguez-Bejarano OH; Roa L; Vargas-Hernández G; Botero-Espinosa L; Parra-López C; Patarroyo MA
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189064. PubMed ID: 38158026
[TBL] [Abstract][Full Text] [Related]
2. A review concerning the breast cancer-related tumour microenvironment.
Rodríguez-Bejarano OH; Parra-López C; Patarroyo MA
Crit Rev Oncol Hematol; 2024 May; 199():104389. PubMed ID: 38734280
[TBL] [Abstract][Full Text] [Related]
3. Detection of neurokinin-1 receptor by immunohistochemistry in canine mammary gland tumours.
Song D; Oh YI; Kim JM; Cheon DS; Kim DY; Seo KW
Vet Med Sci; 2020 Nov; 6(4):958-964. PubMed ID: 32657032
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumour effect of metformin in canine mammary gland tumour cells.
Saeki K; Watanabe M; Tsuboi M; Sugano S; Yoshitake R; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T
Vet J; 2015 Aug; 205(2):297-304. PubMed ID: 25981932
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of canine mammary tumours on the Canary Archipelago in Spain.
Rodríguez J; Santana Á; Herráez P; Killick DR; de Los Monteros AE
BMC Vet Res; 2022 Jul; 18(1):268. PubMed ID: 35821034
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic screening of a library of compounds against metastatic and non-metastatic clones of a canine mammary gland tumour cell line.
Saeki K; Watanabe M; Michishita M; Tsuboi M; Sugano S; Yoshitake R; Murai K; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T
Vet J; 2015 Aug; 205(2):288-96. PubMed ID: 25975851
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic trial of fluvastatin in a cell line xenograft model of canine mammary gland cancer.
Atmane MI; Vigneau AL; Beaudry F; Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2023 Dec; 21(4):634-645. PubMed ID: 37709554
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
9. Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours. Part 2: invasion, angiogenesis, metastasis and therapy.
Santos AA; Matos AJ
Vet J; 2015 Aug; 205(2):144-53. PubMed ID: 25933828
[TBL] [Abstract][Full Text] [Related]
10. Prolactin--to be reconsidered in canine mammary tumourigenesis?
Michel E; Rohrer Bley C; Kowalewski MP; Feldmann SK; Reichler IM
Vet Comp Oncol; 2014 Jun; 12(2):93-105. PubMed ID: 22738741
[TBL] [Abstract][Full Text] [Related]
11. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
[TBL] [Abstract][Full Text] [Related]
12. Progesterone Receptor Signaling in the Breast Tumor Microenvironment.
Boonyaratanakornkit V; McGowan EM; Márquez-Garbán DC; Burton LP; Hamilton N; Pateetin P; Pietras RJ
Adv Exp Med Biol; 2021; 1329():443-474. PubMed ID: 34664251
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of the molecular subtype landscape in canine and human mammary gland tumors.
Bergholtz H; Lien T; Lingaas F; Sørlie T
J Mammary Gland Biol Neoplasia; 2022 Jun; 27(2):171-183. PubMed ID: 35932380
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
15. Proteomic Assessment of the Murine Mammary Gland Extracellular Matrix.
Preston SEJ; Richard VR; Del Rincón SV; Borchers CH; Zahedi RP
Methods Mol Biol; 2023; 2614():261-271. PubMed ID: 36587130
[TBL] [Abstract][Full Text] [Related]
16. cDNA microarray profiles of canine mammary tumour cell lines reveal deregulated pathways pertaining to their phenotype.
Rao NA; van Wolferen ME; van den Ham R; van Leenen D; Groot Koerkamp MJ; Holstege FC; Mol JA
Anim Genet; 2008 Aug; 39(4):333-45. PubMed ID: 18462483
[TBL] [Abstract][Full Text] [Related]
17. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
[TBL] [Abstract][Full Text] [Related]
18. A comparative study between mixed-type tumours from human salivary and canine mammary glands.
Genelhu MC; Cardoso SV; Gobbi H; Cassali GD
BMC Cancer; 2007 Nov; 7():218. PubMed ID: 18045453
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.
Nascimento C; Ferreira F
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188587. PubMed ID: 34237352
[TBL] [Abstract][Full Text] [Related]
20. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
Celià-Terrassa T; Liu DD; Choudhury A; Hang X; Wei Y; Zamalloa J; Alfaro-Aco R; Chakrabarti R; Jiang YZ; Koh BI; Smith HA; DeCoste C; Li JJ; Shao ZM; Kang Y
Nat Cell Biol; 2017 Jun; 19(6):711-723. PubMed ID: 28530657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
